Loading...
OTCM
GNLKQ
Market cap10kUSD
Nov 03, Last price  
0.00USD
Name

Genelink Inc

Chart & Performance

D1W1MN
OTCM:GNLKQ chart
P/E
—
P/S
0.00
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-29.29%
Revenues
2m
-54.40%
12,44837,32416,93063,415128,205304,637396,923175,67497,7446,377,4438,561,4557,839,9724,684,5772,136,142
Net income
-3m
L-20.32%
-920,491-895,844-882,578-1,470,264-1,221,164-2,114,619-1,052,870-584,661-1,560,624-2,603,509-2,716,753-2,634,724-3,830,196-3,051,747
CFO
-2m
L-17.84%
-338,369-315,133-189,792-843,579-1,026,597-1,255,666-321,272-296,523-705,086-1,450,900-2,549,537-1,340,498-2,901,093-2,383,607

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

GeneLink, Inc. specializes in delivering 12-gene DNA profiling services. Beyond genetic analyses, the company also provides clients with bespoke nutritional supplements tailored to individual health needs. Additionally, the firm crafts a comprehensive collection of dermatological products. Established in 1994, GeneLink, Inc. maintains its headquarters in Orlando, Florida.
URL
https://www.genelink.com/
IPO date
Mar 09, 2000
Employees
Domiciled in
US
Incorporated in
US

Valuation

No data to show